IXICO

IXICO

File:Ixico logo.png

IXICO logo

IXICO is a company that specializes in the analysis and interpretation of medical imaging data, particularly in the field of neurology. Founded in 2004, IXICO has developed a range of technologies and services that support the clinical development of new therapies for neurological diseases.

History

IXICO was established as a spin-out from the University of London, with the aim of commercializing advanced imaging techniques developed by its founders. Over the years, the company has grown to become a leader in the field of imaging biomarkers, providing services to pharmaceutical companies and research institutions worldwide.

Services

IXICO offers a variety of services related to the analysis of medical images. These include:

• Image Analysis: Utilizing advanced algorithms to extract quantitative data from medical images.
• Biomarker Development: Identifying and validating imaging biomarkers that can be used in clinical trials.
• Clinical Trial Support: Providing imaging solutions that enhance the efficiency and effectiveness of clinical trials.

Technology

The company employs cutting-edge technology to process and analyze imaging data. This includes the use of machine learning and artificial intelligence to improve the accuracy and reliability of image interpretation.

Applications

IXICO's technologies are applied in various areas of medical research, particularly in the study of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. By providing detailed insights into the progression of these diseases, IXICO aids in the development of new treatments.

Collaborations

IXICO collaborates with numerous pharmaceutical companies, academic institutions, and research organizations. These partnerships are crucial for advancing the understanding of neurological diseases and developing effective therapies.

Related pages

• Medical imaging
• Biomarker
• Neurology
• Clinical trial